Terry White Chemists has
said it will wait until the generic
modified release oxycodone has
the approval of all “necessary and
relevant” authorities, including the
Pharmaceutical Benefits Advisory
Committee, before ranging the
medication, as part of its standard
approach.
A spokesperson said this was of
particular importance when it came
to schedule eight drugs.
API said it would be up to
individual stores/pharmacists as
to whether they would procure
the product as it had no company
or brand recommendation on the
product.
Sigma did not respond to PD
queries at time of writing.The above article was sent to subscribers in Pharmacy Daily's issue from 11 Sep 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Sep 14
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.